Glatz to lead pediatric cardiology division – Washington University School of Medicine in St. Louis

Visit the news hub

Pediatric cardiologist focused on spectrum of congenital heart defects

Courtesy photo

Andrew C. Glatz, MD, an internationally recognized expert in pediatric interventional cardiology, has been selected to lead the Pediatric Cardiology Division of the Department of Pediatrics at Washington University School of Medicine in St. Louis.

He will also become the Louis Larrick Ward Professor of Pediatrics, treating patients at St. Louis Children’s Hospital. His appointment will take effect in March.

Glatz is an associate professor of pediatrics at the University of Pennsylvania Perelman School of Medicine and the founder of the Cardiac Center Clinical Research Core at the Children’s Hospital of Philadelphia (CHOP), where he is also a pediatric interventional cardiologist. He is also one of the site’s three principal investigators for CHOP’s participation in the Pediatric Heart Network, a research consortium funded by the National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH).

“We are excited that Dr. Glatz will take on this role at Washington University School of Medicine,” said Gary A. Silverman, MD, PhD, the Harriet B. Spoehrer Professor, Chief of the Department of Pediatrics and Pediatrician-in-Chief at St. Louis Children’s Hospital. “He brings a wealth of research, administrative, educational and clinical experience to this position. He received his medical degree from Washington University and it is a pleasure to welcome him and his family back to St. Louis.”

Glatz has expertise in treating patients with single-ventricular heart disease who require complex neonatal interventions. His practice is also broadly focused on interventional cardiology and diagnosing and treating congenital heart disease in a variety of patients, from newborns to adults. His work includes quality improvement efforts, including initiatives to reduce radiation exposure in the catheterization lab, as well as the risk of blood clots that can occur during interventional procedures.

Glatz is also a faculty member in the Center for Pediatric Clinical Effectiveness and serves as associate chief for research in the Department of Cardiology. He is the assistant program director of the Pediatric Cardiology Research Training Program and co-chair of the scholarship oversight committees in the Cardiology Department.

His research is funded by grants from the NHBLI, American Heart Association, American College of Cardiology, Children’s Heart Foundation, CHD Coalition, and Big Hearts to Little Hearts. He is also principal investigator of the site and member of the leadership team of the study “Safety of ApiXaban On Pediatric Heart Disease On the Prevention of Embolism” (SAXOPHONE), an international, multicenter randomized trial comparing apixaban to the standard of care for children with congenital heart disease. heart disease that requires long-term anticoagulant therapy to prevent blood clots. He is also co-chair of the “COMPASSON Study of Methods for Neonatal Pulmonary Blood Flow Augmentation: Shunt Versus Stent” (COMPASS), a multicenter randomized trial supported by the NIH/NHLBI Pediatric Heart Network comparing ductal stenting with surgical shunting for newborns with a condition known as ductal-dependent pulmonary blood flow. He is also a founding member and scientific chair of the Congenital Cardiac Research Collaborative.

Glatz received a bachelor’s degree in psychology from Princeton University in 1996 and his medical degree from Washington University School of Medicine in 2002. He completed his internship and residency in pediatrics at the Children’s Hospital of Philadelphia and continued his education with fellowships in pediatric cardiology and interventional pediatric cardiology, also at CHOP. He later earned a master’s degree in clinical epidemiology from the University of Pennsylvania Perelman School of Medicine.

Glatz will take over from David T. Balzer, MD, and Janet Scheel, MD, pediatrics professors who led the division as interim co-directors.

The 1,700 faculty physicians of Washington University School of Medicine are also the medical staff of the children’s hospitals of Barnes-Jewish and St. Louis. The School of Medicine is a leader in medical research, education, and patient care, consistently ranked among the top medical schools in the nation, according to US News & World Report. Through its ties to Barnes Jewish and St. Louis Children’s Hospitals, the School of Medicine is affiliated with BJC HealthCare.

Comments are closed.